Regulation of the IL-23 and IL-12 Balance by Stat3 Signaling in the Tumor Microenvironment
- 3 February 2009
- journal article
- Published by Elsevier BV in Cancer Cell
- Vol. 15 (2), 114-123
- https://doi.org/10.1016/j.ccr.2008.12.018
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Cytokine Signaling Modules in Inflammatory ResponsesImmunity, 2008
- IL-21 Is Produced by Th17 Cells and Drives IL-17 Production in a STAT3-dependent MannerJournal of Biological Chemistry, 2007
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironmentNature Reviews Immunology, 2007
- Selective regulatory function of Socs3 in the formation of IL-17-secreting T cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor–β1The Journal of Experimental Medicine, 2006
- Regulatory T cells, tumour immunity and immunotherapyNature Reviews Immunology, 2006
- The STATs of cancer — new molecular targets come of ageNature Reviews Cancer, 2004
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002